DCGen Co., Ltd.

DCGen Co., Ltd. specializes in in vitro diagnostic (IVD) devices, specifically those focused on genetic testing. Their portfolio includes tools like the DCOF diagnostic device, which analyzes genetic markers for clinical use. These products are designed to enable personalized medical care by providing insights into genetic information relevant to patient health assessments.

DCGen Co., Ltd. is headquartered in South Korea. Their IVD devices, including the DCOF diagnostic tool, are listed in the EU’s eudamed database, which serves as a central registry for medical devices authorized in the European market. This registration reflects their compliance with EU regulatory requirements for IVD General classification.

DCGen Co., Ltd.’s devices fall under the IVD General classification. This classification applies to in vitro diagnostics that do not pose significant risks and are used for routine clinical testing, such as genetic analysis tools. The classification ensures these products meet EU regulatory standards for safety, performance, and proper labeling before being authorized for market placement.

The primary purpose of DCGen Co., Ltd.’s genetic testing devices, such as the DCOF tool, is to support personalized medical care by identifying genetic markers relevant to patient health. These devices help clinicians make informed decisions by providing actionable genetic insights, enabling tailored diagnostic or treatment approaches based on an individual’s unique genetic profile.